Home › Pancreatic Ductal Carcinoma › Michigan
Pancreatic Ductal Carcinoma clinical trials in Michigan
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in Michigan.
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
- Site 03, Grand Rapids
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07259317Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
- Henry Ford Centre, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06850623From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.